PREMIER NUTRA PHARMA Inc.July 8, 2022

FDA 483 - PREMIER NUTRA PHARMA Inc. - July 08, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PREMIER NUTRA PHARMA Inc.

Record Details

PREMIER NUTRA PHARMA Inc. in Carlsbad, CA, a drug manufacturer, was inspected and found to have significant deficiencies across its quality control, manufacturing processes, and facility maintenance. Key issues include releasing contaminated products without proper testing, lacking essential batch records and quality unit oversight, and maintaining unsanitary conditions. These conditions pose a public health risk due to potential product contamination.

Company: PREMIER NUTRA PHARMA Inc.
Inspection Date: July 8, 2022
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations IV
People: Rachel C. Stanton
Roger F. Zabinski (Investigator)

Open in Dashboard

ID · d6436604-4f64-4382-9093-45bdef639ed6